TSS
ONSIW

Two Sigma Securities’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Two Sigma Securities’s Portfolio ONSIW Stock Details ONSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,141
Closed -$1K – 2132
2017
Q3 		$1K Buy
+11,141
New +$1.42K ﹤0.01% 892

Other funds holding ONSIW

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Two Sigma Securities's ONSIW Position: Q4 2017 in Review

Two Sigma Securities sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q4 2017, closing a stake of 11,141 shares — an estimated $1K sold.

Two Sigma Securities first reported a position in ONSIW in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 5 funds tracked by Wall St. Rank hold ONSIW as of Q4 2017.

  • Two Sigma Securities reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q4 2017 after selling out during the quarter.
  • Two Sigma Securities sold 11,141 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q4 2017, an estimated $1K.
  • Two Sigma Securities first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q3 2017 and held it in 1 quarter.
  • Two Sigma Securities's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $1K in Q3 2017.
  • 5 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q4 2017.

Based on Two Sigma Securities's 13F filing for Q4 2017, filed 14 Feb 2018.